leadf
logo-loader
viewMMJ Group Holdings Ltd

MMJ Group investment MediPharm Labs can serve global medical cannabis market after gaining GMP certification

MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products.

MMJ Group Holdings Ltd - MMJ Group Holdings investment MediPharm Labs receives first GMP certification to serve global medical cannabis market
MediPharm Labs’ 70,000 square foot Canadian production facility in Canada features ISO standard built clean rooms

MMJ Group Holdings Ltd (ASX:MMJ) investee MediPharm Labs Corp (TSX:LABS) (OTCQX:MEDIF) (FSE:MLZ) has received Australian Therapeutic Goods Administration (TGA) confirmation that its Canadian manufacturing facility meets the requirements for Good Manufacturing Practice for medicinal products.

This marks a key business breakthrough and will increase MediPharm’s global manufacturing capabilities.

The TGA is the branch of the Australian Government’s Department of Health responsible for regulating therapeutic goods, including prescription medicines, vaccines and medical devices. 

Confirmation came after an intensive audit under the TGA’s clearance program for the overseas manufacture of medicine and Active Pharmaceutical Ingredients (APIs) for supply to Australia.

MediPharm Labs demonstrated that its state-of-the-art Canadian facility met the PIC/S GMP requirements as a Medicines Manufacturer of cannabis as a medicine (oral liquids) in accordance with Part I of the PIC/S GMP guide and cannabis as an API in accordance with Part II of the PIC/S GMP.

The site was also successfully audited for chemical testing and analysis of cannabis as a medicine.

GMP certification 

MediPharm Labs received its certification less than 60 days from its TGA inspection, which was completed between October 14 and 16. 

While the certificate was issued by Australia’s TGA to permit MediPharm Labs’ Canadian facility to deliver APIs and final medicinal products to the Australian medical cannabis market, upon MediPharm Labs’ Australian production facility receiving its GMP certificate, the company will be positioned to leverage a global supply chain to sell cannabis APIs and finished products to countries across Europe due to a Mutual Recognition Agreement between Australia and the EU.

MediPharm Labs chief executive officer Pat McCutcheon said: “I cannot overstate the importance and prestige of earning our first GMP certification.

“GMP certification is the ticket to gaining access to the rapidly growing global medical cannabis market and it is the recognised standard by which pharmaceutical manufacturers and consumer packaged goods companies worldwide judge their supply partners.

"We thank the TGA for being the first to formally recognise the quality of our facilities and processes.

"Although this certification specifically applies to the Australian market, it adds to a body of evidence that will assist us in our quest to obtain the EU-GMP certification to directly sell into the EU market.”

First for an extraction-only company in Canada

With the formal certificate now issued, MediPharm Labs is the first Canadian extraction-only cannabis company to announce TGA GMP certification, reflecting that the company’s Canadian facility was purpose-built to GMP standards.

This internationally recognised certification is only granted to companies that can demonstrate consistency, precision and quality in all stages of production and are able to comply with GMP principles for manufacturing Active Pharmaceutical Ingredients and final medicinal products.

Quick facts: MMJ Group Holdings Ltd

Price: 0.092 AUD

ASX:MMJ
Market: ASX
Market Cap: $21.16 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Full interview: MMJ Group sees strong future for cannabis sector amid global...

MMJ Group (ASX: MMJ) Non-Executive Director Michael Curtis joined Steve Darling from Proactive Vancouver to discuss his thoughts on the cannabis industry and how that sector is doing during the Corona outbreak. Cannabis stores were deemed an essential service. Curtis also talked about how...

on 14/5/20

3 min read